Cargando…

Myeloid Cell Mediated Ilmmune Suppression in Pancreatic Cancer

Detalles Bibliográficos
Autores principales:	Kemp, Samantha B., Pasca di Magliano, Marina, Crawford, Howard C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529393/ https://www.ncbi.nlm.nih.gov/pubmed/34303882 http://dx.doi.org/10.1016/j.jcmgh.2021.07.006

Ejemplares similares

Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer
por: Du, Wenting, et al.
Publicado: (2021)

Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice
por: Zhang, Yaqing, et al.
Publicado: (2017)

The Gustatory Sensory G-Protein GNAT3 Suppresses Pancreatic Cancer Progression in Mice
por: Hoffman, Megan T., et al.
Publicado: (2020)

Myeloid Cell-Derived HB-EGF Drives Tissue Recovery After Pancreatitis
por: Wen, Hui-Ju, et al.
Publicado: (2019)

Apolipoprotein E Promotes Immune Suppression in Pancreatic Cancer through NF-κB–Mediated Production of CXCL1
por: Kemp, Samantha B., et al.
Publicado: (2021)

Beta 1 integrin signaling mediates pancreatic ductal adenocarcinoma resistance to MEK inhibition
por: Brannon, Arthur, et al.
Publicado: (2020)

Immune cells in pancreatic cancer: Joining the dark side
por: Zhang, Yaqing, et al.
Publicado: (2014)

Tyrosine Sulfation: A New Player and Potential Target in Pancreatic Cancer
por: Zhang, Yaqing, et al.
Publicado: (2023)

Pancreatic Fibroblast Heterogeneity: From Development to Cancer
por: Garcia, Paloma E., et al.
Publicado: (2020)

Kras as a key oncogene and therapeutic target in pancreatic cancer
por: Collins, Meredith A., et al.
Publicado: (2014)

Hypoxia promotes an inflammatory phenotype of fibroblasts in pancreatic cancer
por: Mello, Ashley M., et al.
Publicado: (2022)

3373 Modulation of Hedgehog Signaling Alters Immune Infiltration in Pancreatic Cancer
por: Steele, Nina, et al.
Publicado: (2019)

Back to the drawing board: Re-thinking the role of GLI1 in pancreatic carcinogenesis
por: Hogenson, Tara L., et al.
Publicado: (2016)

Myeloid cells are required for PD-1/PD-L1 checkpoint activation and the establishment of an immunosuppressive environment in pancreatic cancer
por: Zhang, Yaqing, et al.
Publicado: (2017)

Mitogen-activated Protein Kinase Kinase Activity Maintains Acinar-to-Ductal Metaplasia and Is Required for Organ Regeneration in Pancreatitis
por: Halbrook, Christopher J., et al.
Publicado: (2016)

Arginase 1 is a key driver of immune suppression in pancreatic cancer
por: Menjivar, Rosa E, et al.
Publicado: (2023)

Usp9x Promotes Survival in Human Pancreatic Cancer and Its Inhibition Suppresses Pancreatic Ductal Adenocarcinoma In Vivo Tumor Growth()
por: Pal, Anupama, et al.
Publicado: (2017)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

Utilizing past and present mouse systems to engineer more relevant pancreatic cancer models
por: DeCant, Brian T., et al.
Publicado: (2014)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer
por: Yan, Wei, et al.
Publicado: (2023)

Early pancreatic islet fate and maturation is controlled through RBP-Jκ
por: Cras-Méneur, Corentin, et al.
Publicado: (2016)

Epithelial Notch signaling is a limiting step for pancreatic carcinogenesis
por: Thomas, Marsha M, et al.
Publicado: (2014)

ATDC binds to KEAP1 to drive NRF2-mediated tumorigenesis and chemoresistance in pancreatic cancer
por: Purohit, Vinee, et al.
Publicado: (2021)

KDM6A Regulates Cell Plasticity and Pancreatic Cancer Progression by Noncanonical Activin Pathway
por: Yi, Zhujun, et al.
Publicado: (2021)

Change isn't always better
por: Schofield, Heather, et al.
Publicado: (2015)

Pancreatic cancer is marked by complement-high blood monocytes and tumor-associated macrophages
por: Kemp, Samantha B, et al.
Publicado: (2021)

Metastatic Pancreatic Cancer Is Dependent on Oncogenic Kras in Mice
por: Collins, Meredith A., et al.
Publicado: (2012)

Pancreatic tumors exhibit myeloid-driven amino acid stress and upregulate arginine biosynthesis
por: Apiz Saab, Juan J, et al.
Publicado: (2023)

ATDC is required for the initiation of KRAS-induced pancreatic tumorigenesis
por: Wang, Lidong, et al.
Publicado: (2019)

Mesenchymal Stem Cells Promote Pancreatic Tumor Growth by Inducing Alternative Polarization of Macrophages()()
por: Mathew, Esha, et al.
Publicado: (2016)

Fbxw7 Deletion Accelerates Kras(G12D)-Driven Pancreatic Tumorigenesis via Yap Accumulation()()()
por: Zhang, Qiang, et al.
Publicado: (2016)

Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
por: Kerk, Samuel A, et al.
Publicado: (2022)

Combinatorial Gli activity directs immune infiltration and tumor growth in pancreatic cancer
por: Scales, Michael K., et al.
Publicado: (2022)

Pancreatic HIF2α Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm
por: Schofield, Heather K., et al.
Publicado: (2017)

WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer
por: Du, Wenting, et al.
Publicado: (2022)

Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia of the Elderly: Review of Literature and New Perspectives
por: Magliano, Gabriele, et al.
Publicado: (2020)

Targeting myeloid suppressive cells revives cytotoxic anti-tumor responses in pancreatic cancer
por: Sarhan, Dhifaf, et al.
Publicado: (2022)

Activated T cells sustain myeloid-derived suppressor cell-mediated immune suppression
por: Pinton, Laura, et al.
Publicado: (2015)

Putting the Cell of Origin for Pancreatic Cancer Into its Proper Context
por: Crawford, Howard C.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ioe0k2vs1s50m8306746ikqh1h